SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Brooks Laboratories - Quaterly Results

18 May 2024 Evaluate
The sales moved up 40.49% to Rs. 177.22 millions for the March 2024 quarter as compared to Rs. 126.14 millions during the year-ago period.The Total Profit for the quarter ended March 2024 of Rs. 3.04 millions grew from Rs.-7.12 millions Operating profit Margin for the quarter ended March 2024 improved to 10.34% as compared to -0.93% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 177.22 126.14 40.49 794.86 555.38 43.12 794.86 555.38 43.12
Other Income 6.54 0.27 2322.22 9.56 1.15 731.30 9.56 1.15 731.30
PBIDT 10.34 -0.93 -1211.83 41.73 -56.99 -173.22 41.73 -56.99 -173.22
Interest 2.74 1.84 48.91 8.45 7.67 10.17 8.45 7.67 10.17
PBDT 7.60 -2.77 -374.37 33.28 -64.66 -151.47 33.28 -64.66 -151.47
Depreciation 4.56 4.35 4.83 17.73 17.17 3.26 17.73 17.17 3.26
PBT 3.04 -7.12 -142.70 15.55 -81.83 -119.00 15.55 -81.83 -119.00
TAX 0.00 0.00 0.00 0.26 0.00 0.00 0.26 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 3.04 -7.12 -142.70 15.29 -81.83 -118.69 15.29 -81.83 -118.69
Equity 262.47 247.03 6.25 262.47 247.03 6.25 262.47 247.03 6.25
PBIDTM(%) 5.83 -0.74 -891.35 5.25 -10.26 -151.16 5.25 -10.26 -151.16

Brooks Laboratories Share Price

67.22 0.83 (1.25%)
15-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.45
Dr. Reddys Lab 1279.25
Cipla 1381.50
Zydus Lifesciences 1087.75
Lupin 2273.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: